Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension
Authors
Keywords
-
Journal
SCANDINAVIAN CARDIOVASCULAR JOURNAL
Volume 48, Issue 4, Pages 223-233
Publisher
Informa UK Limited
Online
2014-06-10
DOI
10.3109/14017431.2014.931595
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sustained effect of macitentan, a novel oral endothelin receptor antagonist, on exercise capacity and the association of its measure with long-term outcomes in pulmonary arterial hypertension
- (2014) N. Galie et al. EUROPEAN HEART JOURNAL
- Baseline and Follow-up 6-Min Walk Distance and Brain Natriuretic Peptide Predict 2-Year Mortality in Pulmonary Arterial Hypertension
- (2013) Jason S. Fritz et al. CHEST
- Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
- (2013) Tomás Pulido et al. NEW ENGLAND JOURNAL OF MEDICINE
- Riociguat for the Treatment of Pulmonary Arterial Hypertension
- (2013) Hossein-Ardeschir Ghofrani et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Evaluation of Long-term Survival From Time of Diagnosis in Pulmonary Arterial Hypertension From the REVEAL Registry
- (2012) Raymond L. Benza et al. CHEST
- Validation of 6-Minute Walk Distance as a Surrogate End Point in Pulmonary Arterial Hypertension Trials
- (2012) Nicole B. Gabler et al. CIRCULATION
- Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension?
- (2012) Gianluigi Savarese et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension
- (2011) N. Nickel et al. EUROPEAN RESPIRATORY JOURNAL
- Clinical Pharmacokinetics and Drug-Drug Interactions of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension
- (2011) Jürgen Venitz et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: An observational study
- (2011) Kristina Kemp et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Simvastatin as a Treatment for Pulmonary Hypertension Trial
- (2010) M. R. Wilkins et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Integration of Clinical and Hemodynamic Parameters in the Prediction of Long-term Survival in Patients With Pulmonary Arterial Hypertension
- (2010) Garvan C. Kane et al. CHEST
- Predicting Survival in Pulmonary Arterial Hypertension
- (2010) Raymond L. Benza et al. CIRCULATION
- Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era
- (2010) Marc Humbert et al. CIRCULATION
- Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
- (2010) M. Humbert et al. EUROPEAN RESPIRATORY JOURNAL
- Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult
- (2010) R Hesselstrand et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
- (2009) N. Galie et al. EUROPEAN HEART JOURNAL
- Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation
- (2009) T. Thenappan et al. EUROPEAN RESPIRATORY JOURNAL
- Guidelines for the diagnosis and treatment of pulmonary hypertension
- (2009) et al. EUROPEAN RESPIRATORY JOURNAL
- Updated Clinical Classification of Pulmonary Hypertension
- (2009) Gérald Simonneau et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started